Skip to content

Clinical trials

Completed Phase 1 Schizophrenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 1 Status: Completed Clear all

272 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20039
200412
20059
200612
200718
200813
200921
201012
201116
201216
201318
201419
201512
201610
20176
201811
20198
20208
202114
20227
20236
20248
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed272

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.31
Otsuka Pharmaceutical Development & Commercialization, Inc.26
GlaxoSmithKline13
Yale University9
Pfizer8
Luye Pharma Group Ltd.7
Merck Sharp & Dohme LLC7
Sumitomo Pharma America, Inc.6
Wyeth is now a wholly owned subsidiary of Pfizer6
Biogen5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia272
Psychotic Disorders57
Mood Disorders23
Bipolar Disorder11
Mental Disorders8
Schizophrenia Spectrum and Other Psychotic Disorders6
Cognitive Dysfunction5
Alzheimer Disease3
Cognition Disorders3
Depressive Disorder2

Trials

Showing 1 to 25 of 272. Each trial links to its page on Pharma Observatory.

172 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.